Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.
Also called NCT02790606
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 110 participants
- Sponsor
- Registry
-
NCT02790606
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02790606. Allocation not applicable; no masking; primary purpose treatment. Start 2016-07 (actual); primary completion 2017-08 (actual). Results posted on 2019-02-26.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA)
- Acronym
- AVeVA
- Condition
- Stenosis
- Condition
- Restenosis
- Intervention (Device)
- Covera(TM) Vascular Covered Stent
- Lead sponsor
- C. R. Bard
Record details
- Record id
cardio:ct-nct02790606- Content hash
f35037d0b46e1733fb54c756f3ffde8f6d0982fbcd409210574e966e87d3d3a5